Artificial intelligence (AI) and machine learning (ML)-enabled digital health technologies have great potential to improve patient care, strengthen diagnostic capabilities and enhance treatment options. Governments and healthcare professionals understand the transformative benefits of AI/ML Software as a Medical Device (SaMD); however, the product development lifecycle for AI technologies poses a range of challenges to current regulatory frameworks.